Cryoport director proposes $358K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cryoport, Inc. director Ramkumar Mandalam reported a proposed sale of 23,214 common shares, with an aggregate market value of $358,452.02 and an approximate sale date of June 8, 2026. The shares were acquired on June 6, 2026 through restricted stock vesting under a registered plan.
Key Figures
Key Terms
Restricted Stock Vesting technical
Registered Plan technical
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.